Anatomy of a top revisited – Valeant Pharmaceuticals $VRX
| |

Anatomy of a top revisited – Valeant Pharmaceuticals $VRX

More bad news continues to come out from the Valeant Pharmaceuticals (VRX) story. We have no idea how this ends up but the writing has been on the wall for months for the stock. Due to popular demand here is another look at Gary’s article from last week, promptly titled, “Anatomy of a top.” Originally Published on…